Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.800
0.00 (0.00%)
At close: Feb 6, 2026

HRGN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-6.53-7.73-8.95-6.07-7.98-4.87
Depreciation & Amortization
0.10.170.130.070.110.18
Stock-Based Compensation
2.232.43.461.030.981.14
Other Operating Activities
----0-0.42-0.02
Change in Accounts Receivable
-0-0.23-0---
Change in Inventory
0.09-0.03-0.05---
Change in Accounts Payable
-0.190.01-0.240.010.65-0.21
Change in Other Net Operating Assets
-0.110.56-1.3-0.144.04-0.28
Operating Cash Flow
-4.29-4.85-6.94-5.11-2.63-4.04
Capital Expenditures
---0.01-0.01--0.01
Investing Cash Flow
---0.01-0.01--0.01
Short-Term Debt Issued
-0.5----
Long-Term Debt Issued
-----0.4
Total Debt Issued
-0.5---0.4
Short-Term Debt Repaid
--0.5----
Total Debt Repaid
--0.5----
Net Debt Issued (Repaid)
-----0.4
Issuance of Common Stock
26.916.145.062.843.8
Repurchase of Common Stock
------0.04
Financing Cash Flow
26.916.145.062.844.16
Foreign Exchange Rate Adjustments
0.02-0.01----
Net Cash Flow
-2.272.05-0.81-0.050.220.11
Free Cash Flow
-4.29-4.85-6.95-5.11-2.63-4.05
Free Cash Flow Margin
-577.25%-1128.37%-6747.57%---
Free Cash Flow Per Share
-0.27-0.33-0.52-0.45-0.26-0.46
Cash Interest Paid
0.010.040.010.01--
Levered Free Cash Flow
-2.09-2.36-2.41-6.370.58-2.51
Unlevered Free Cash Flow
-2.09-2.34-2.4-6.370.58-2.51
Change in Working Capital
-0.090.31-1.59-0.144.69-0.49
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.